首页|穴位贴敷联合理冲汤加减治疗气虚血瘀型盆腔炎性疾病后遗症临床研究

穴位贴敷联合理冲汤加减治疗气虚血瘀型盆腔炎性疾病后遗症临床研究

扫码查看
目的 观察穴位贴敷联合理冲汤加减治疗气虚血瘀型盆腔炎性疾病后遗症的抗炎作用及对盆腔血流动力、免疫学指标的影响.方法 将98 例气虚血瘀型盆腔炎性疾病后遗症患者按照随机数字表法分为 2 组.对照组 49例予理冲汤加减治疗,治疗组49 例予穴位贴敷联合理冲汤加减治疗.比较2 组临床疗效.比较2 组治疗前后中医证候评分、子宫动脉搏动指数(PI)、舒张末期血流速度(EDV)、阻力指数(RI)、盆腔积液最大深径、盆腔包块直径、细胞间黏附分子1(ICAM-1)、单核细胞趋化蛋白-1(MCP-1)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)、CD4+、CD8+、补体C3 水平.结果 治疗组总有效率97.96%(48/49),对照组总有效率 83.67%(41/49),治疗组疗效优于对照组(P<0.05).治疗后,2 组下腹疼痛或坠痛、经行疼痛加重、精神萎靡、食少纳呆、经期延长或月经量多、经血淡暗或有块、体倦乏力、色白质稀、带下量多评分均较本组治疗前降低(P<0.05),且治疗组均低于对照组(P<0.05).治疗后,2 组盆腔积液最大深径、盆腔包块直径均较本组治疗前减小(P<0.05),且治疗组小于对照组(P<0.05).治疗后,2 组RI、PI均较本组治疗前降低(P<0.05),EDV较本组治疗前升高(P<0.05),且治疗组RI、PI低于对照组(P<0.05),EDV高于对照组(P<0.05).治疗后,2 组ICAM-1、MCP-1、GM-CSF水平均较本组治疗前降低(P<0.05),且治疗组低于对照组(P<0.05).治疗后,2 组CD8+水平均较本组治疗前降低(P<0.05),CD4+、补体C3 水平均较本组治疗前升高(P<0.05),且2 组组间比较差异有统计学意义(P<0.05).结论 穴位贴敷联合理冲汤加减治疗盆腔炎性疾病后遗症患者,可提升抗炎效果,改善盆腔血流动力学及免疫学指标水平,减少盆腔积液及包块.
Effect of acupoint application combined with modified Lichong Decoction on sequelae of pelvic inflammatory disease of Qi-deficiency and blood-stasis type
Objective To observe the effect of acupoint application combined with modified Lichong Decoction on sequelae of pelvic inflammatory disease(PID)of Qi-deficiency and blood-stasis type and its impacts on hemodynamic and immunological indexes.Methods Ninety-eight patients with sequelae of PID of Qi-deficiency and blood-stasis type were assigned in a 1∶1 ratio to modified Lichong Decoction(control group)or acupoint application plus modified Lichong Decoction(treatment group)by a random number table.The clinical efficacy,traditional Chinese medicine(TCM)symptom scores,pulsation index(PI)in uterine artery,end-diastolic velocity(EDV),resistance index(RI),the maximum depth diameter and the diameter of pelvic mass,intercellular adhesion molecule 1(ICAM-1),monocyte chemotactic protein-1(MCP-1),granulocyte-macrophage colony-stimulating factor(GM-CSF),CD4+,CD8+,and complement component C3 were compared.Results The total effective rate of the treatment group was significantly higher than that of the control group(97.96%[48/49]vs 83.67%[41/49],P<0.05).TCM symptom scores(lower abdominal pain or falling pain,aggravation of menstruation,apatheia,poor appetite,menstrual extension or menorrhagia,pale or lumpy menstrual blood,body fatigue,color white matter thin,more leucorrhea)in the both groups were significantly decreased(P<0.05),which decreased notably in the treatment group compared with the control group(P<0.05).The maximum depth of pelvic effusion and the diameter of pelvic mass in the both groups were significantly decreased(P<0.05),which were significantly smaller in the treatment group than in the control group(P<0.05).Significantly decreased RI and PI levels,and increased EDV level were found in the both groups(all P<0.05),which were significantly pronounced in the treatment group(all P<0.05).The contents of ICAM-1,MCP-1 and GM-CSF in the both groups were significantly decreased(P<0.05),which in the treatment group were significantly lower than those in the control group(P<0.05).Significantly decreased CD8+levels,and increased CD4+and complement C3 levels were found in the both groups(all P<0.05),and the different was significant between groups for the above indexes(all P<0.05).Conclusion The combination of acupoint application and modified Lichong Decoction on sequelae of PID can improve the anti-inflammatory effect,improve their hemodynamics and immunological indexes,reduce pelvic effusion and mass.

Pelvic inflammatory diseaseAcupoint application therapyLichong decoction

石琳子、张启丽、张欣欣

展开 >

安徽省滁州市中西医结合医院中医妇科,安徽 滁州 239000

盆腔炎性疾病 穴位贴敷疗法 理冲汤

2020年度中国民族医药学会科研项目

2020ZY076-570101

2024

河北中医
河北省医学情报研究所,河北省中医药学会

河北中医

CSTPCD
影响因子:0.951
ISSN:1002-2619
年,卷(期):2024.46(9)